For the year ending 2025-12-31, EOLS had -$33,126K decrease in cash & cash equivalents over the period. -$45,706K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -51,641 |
| Depreciation and amortization | 7,506 |
| Stock-based compensation | 20,698 |
| Provision for credit losses and inventory | 6,515 |
| Amortization of operating lease right-of-use assets | 1,237 |
| Amortization of debt discount and issuance costs | 1,289 |
| Deferred income taxes | 21 |
| Revaluation of contingent royalty obligation payable to evolus founders | -6,381 |
| Non-cash in-process research and development expense | 0 |
| Other adjustments to operating activities | 967 |
| Inventories | 11,124 |
| Accounts receivable | 11,509 |
| Prepaid expenses | 355 |
| Accounts payable | 10,103 |
| Accrued expenses | -6,364 |
| Accrued litigation settlement | 0 |
| Operating lease liabilities | -758 |
| Other operating assets | 2,469 |
| Net cash used in operating activities | -42,265 |
| Purchases of property and equipment | 3,441 |
| Additions to capitalized software | 5,011 |
| Net cash used in investing activities | -8,452 |
| Payment of contingent royalty obligation to evolus founders | 6,202 |
| Proceeds from issuance and modification of debt instruments | 25,000 |
| Payments for debt modification fees and debt issuance costs | 2,610 |
| Proceeds from follow-on offering | 0 |
| Payments for offering costs | 0 |
| Issuance of common stock in connection with incentive equity plan | 1,164 |
| Payment of finance lease obligations | 15 |
| Tax withholding paid on behalf of employees for net share settlement | 0 |
| Net cash provided by financing activities | 17,337 |
| Effect of exchange rates on cash and cash equivalents | 254 |
| Net increase (decrease) in cash and cash equivalents | -33,126 |
| Cash and cash equivalents, beginning of period | 86,952 |
| Cash and cash equivalents, end of period | 53,826 |
Evolus, Inc. (EOLS)
Evolus, Inc. (EOLS)